Correlation Between ImmuCell and Adial Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ImmuCell and Adial Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ImmuCell and Adial Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ImmuCell and Adial Pharmaceuticals WT, you can compare the effects of market volatilities on ImmuCell and Adial Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ImmuCell with a short position of Adial Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ImmuCell and Adial Pharmaceuticals.

Diversification Opportunities for ImmuCell and Adial Pharmaceuticals

0.2
  Correlation Coefficient

Modest diversification

The 3 months correlation between ImmuCell and Adial is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding ImmuCell and Adial Pharmaceuticals WT in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Adial Pharmaceuticals and ImmuCell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ImmuCell are associated (or correlated) with Adial Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Adial Pharmaceuticals has no effect on the direction of ImmuCell i.e., ImmuCell and Adial Pharmaceuticals go up and down completely randomly.

Pair Corralation between ImmuCell and Adial Pharmaceuticals

If you would invest  381.00  in ImmuCell on September 4, 2024 and sell it today you would earn a total of  32.00  from holding ImmuCell or generate 8.4% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy1.56%
ValuesDaily Returns

ImmuCell  vs.  Adial Pharmaceuticals WT

 Performance 
       Timeline  
ImmuCell 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in ImmuCell are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile fundamental indicators, ImmuCell may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Adial Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Adial Pharmaceuticals WT has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Adial Pharmaceuticals is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

ImmuCell and Adial Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ImmuCell and Adial Pharmaceuticals

The main advantage of trading using opposite ImmuCell and Adial Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ImmuCell position performs unexpectedly, Adial Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Adial Pharmaceuticals will offset losses from the drop in Adial Pharmaceuticals' long position.
The idea behind ImmuCell and Adial Pharmaceuticals WT pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities